CUAMC
SNDX icon

China Universal Asset Management Company’s Syndax Pharmaceuticals SNDX Stock Holding History

China Universal Asset Management Company’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$308K Sell
14,102
-1,550
-10% -$32.2K 0.02% 318
2026
Q1 		$366K Buy
15,652
+1,489
+11% +$32.4K 0.03% 292
2025
Q4 		$298K Sell
14,163
-936
-6% -$16.3K 0.02% 304
2025
Q3 		$232K Sell
15,099
-2,183
-13% -$28.6K 0.02% 321
2025
Q2 		$162K Buy
17,282
+161
+0.9% +$1.77K 0.02% 329
2025
Q1 		$210K Sell
17,121
-978
-5% -$13.8K 0.02% 310
2024
Q4 		$239K Buy
18,099
+1,732
+11% +$29.6K 0.02% 315
2024
Q3 		$315K Buy
16,367
+6,383
+64% +$132K 0.03% 265
2024
Q2 		$205K Sell
9,984
-6,354
-39% -$133K 0.03% 239
2024
Q1 		$389K Buy
16,338
+8,280
+103% +$185K 0.05% 207
2023
Q4 		$174K Buy
8,058
+6,276
+352% +$96.5K 0.03% 218
2023
Q3 		$25.9K Buy
1,782
+880
+98% +$16.6K 0.01% 282
2023
Q2 		$18.9K Sell
902
-26
-3% -$541 0.01% 274
2023
Q1 		$19.6K Buy
928
+316
+52% +$7.86K 0.01% 224
2022
Q4 		$15.6K Buy
612
+82
+15% +$1.91K 0.01% 192
2022
Q3 		$13K Buy
+530
New +$11.9K 0.01% 184

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

China Universal Asset Management Company's SNDX Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Syndax Pharmaceuticals (SNDX) stake by 9.9% in Q2 2026, selling an estimated $32.2K and leaving 14,102 shares worth $308K. The position accounts for 0.02% of the portfolio, ranked #318.

China Universal Asset Management Company first reported a position in SNDX in Q3 2022 and has held it in 16 quarters since. The position peaked at $389K in Q1 2024. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • China Universal Asset Management Company held 14,102 shares of Syndax Pharmaceuticals worth $308K as of Q2 2026.
  • China Universal Asset Management Company sold 1,550 Syndax Pharmaceuticals shares in Q2 2026, an estimated $32.2K.
  • Syndax Pharmaceuticals made up 0.02% of China Universal Asset Management Company's portfolio in Q2 2026, its #318 holding.
  • China Universal Asset Management Company first reported a position in Syndax Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's Syndax Pharmaceuticals position peaked at $389K in Q1 2024.
  • 242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.